This collection highlights a selection of the best articles published in 2021 from the Cardiovascular Biologics and Regenerative Medicine section of Frontiers in Cardiovascular Medicine.
The specialty section Cardiovascular Biologics and Regenerative Medicine welcomes articles related to all aspects of cardiac regeneration including, but not limited to, biomaterials, cell therapy, gene therapy, genomics, proteomics and hybrid therapy.
Frontiers in Cardiovascular Medicine publishes peer-reviewed research articles across basic, translational, and clinical cardiovascular medicine. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal provides a unique forum that helps scientists and clinicians to disseminate novel discoveries and technologies widely, advance scientific knowledge rapidly, and propose new paradigms and theories.
The Editors of Frontiers in Cardiovascular Medicine encourage submission of Original Research Articles (clinical or preclinical), Reviews, Mini Reviews and Case Reports. Original research articles include manuscripts reporting results from clinical investigations, including Phase I-III trials and population studies. Reports from experimental studies from related areas such as physiology, pathophysiology, cellular and molecular biology, genetics, or pharmacology may be considered as as long as they relate to new understandings of pathogenic mechanisms or novel therapeutic approaches relevant to human disease. Articles related to medical education or the future development of medicine may also be considered.
This collection highlights a selection of the best articles published in 2021 from the Cardiovascular Biologics and Regenerative Medicine section of Frontiers in Cardiovascular Medicine.
The specialty section Cardiovascular Biologics and Regenerative Medicine welcomes articles related to all aspects of cardiac regeneration including, but not limited to, biomaterials, cell therapy, gene therapy, genomics, proteomics and hybrid therapy.
Frontiers in Cardiovascular Medicine publishes peer-reviewed research articles across basic, translational, and clinical cardiovascular medicine. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal provides a unique forum that helps scientists and clinicians to disseminate novel discoveries and technologies widely, advance scientific knowledge rapidly, and propose new paradigms and theories.
The Editors of Frontiers in Cardiovascular Medicine encourage submission of Original Research Articles (clinical or preclinical), Reviews, Mini Reviews and Case Reports. Original research articles include manuscripts reporting results from clinical investigations, including Phase I-III trials and population studies. Reports from experimental studies from related areas such as physiology, pathophysiology, cellular and molecular biology, genetics, or pharmacology may be considered as as long as they relate to new understandings of pathogenic mechanisms or novel therapeutic approaches relevant to human disease. Articles related to medical education or the future development of medicine may also be considered.
